Founded in 1999, Zygogen is a premier provider of zebrafish research products and services for academic and commercial applications. We provide proprietary zebrafish embryos directly to researchers for rapid, cost-effective, compound screening in their own laboratories. We also offer a full complement of zebrafish-based services, including screening assays and gene function analysis. Our transgenic Z-TagSM zebrafish are engineered with organ and tissue-specific fluorescence to produce robust readouts that enable high content, in vivo screening. Individual gene targets are rapidly interrogated using our exclusive Morphant antisense knock-down embryos.
Zygogen is differentiated from its competitors in three ways.
- Our sole focus is on providing zebrafish products and services
- We have exclusive rights to Z-Tag and Morphant embryos
- We are a pioneer in automating zebrafish compound screening
Zygogen believes that the full commercial value of the zebrafish model system is realized by using Z-Tag embryos for automated secondary screening of hits derived from high throughput primary screens and by using Morphant gene knockdown embryos to investigate target classes. Zebrafish have been used as a discovery tool by scientists in diverse therapeutic areas as well as toxicity and safety pharmacology.
Nina Sawczuk, CEO
Phone: (404) 523-7309
For more information, visit Zygogen at their company website.